Here you will find the Funding Position of ICB Commissioned High-Cost Drugs within the Lancashire and South Cumbria Health Economy.

A number of High-Cost Drugs, devices, procedures and products have been excluded from the scope of the national tariff of Payment by Results. These are listed on tab 13b of the following document:

2024/25 Annex A: The national tariff workbook

High-cost drugs are commissioned by:

• NHS England or

• Integrated Care Board

The funding position of medicines directly commissioned by NHS England can be accessed via the NHS England website.

Refer to the Manual for Prescribed Specialised Services for further information about prescribed specialised services, some of which are directly commissioned by NHS England and some by ICBs.